Work

Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.12138

Authors: Yoshihiro Masui, Tatsuya Yoshida, Ryoko Inaba Higashiyama, Shigehiro Yagishita, Mayu Ohuchi, Ken Masuda, Yuki Shinno, Yuji Matsumoto, Tomonori Mizutani, Yusuke Okuma, Hidehito Horinouchi, Shohei Koyama, Noboru Yamamoto, Akinobu Hamada, Yasushi Goto

Institutions: National Cancer Center Hospital, National Cancer Centre Japan

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162494183

Cites:

Cited by:

Related to: